O'Dell Group’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY.RT
JCI
BC
TNB
WAM
IAIM
O'Dell Group's BMY.RT Position: Q1 2021 in Review
O'Dell Group sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 14,878 shares — an estimated $10K sold.
O'Dell Group first reported a position in BMY.RT in Q4 2019 and held it in 2 quarters. The position peaked at $33K in Q4 2019. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.
- O'Dell Group reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
- O'Dell Group sold 14,878 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $10K.
- O'Dell Group first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 2 quarters.
- O'Dell Group's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $33K in Q4 2019.
- 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.
Based on O'Dell Group's 13F filing for Q1 2021, filed 29 Apr 2021.